Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Equity Capital Markets

Gaudium IVF and Women Health Limited / Equity Capital Markets

Gaudium IVF and Women Health Limited (GAUD12 IN)

<ul>
<li>Gaudium IVF IPO will open for subscription on February 20 and close on February 24, with listing on February 27. The IPO price band has been set at INR 75–79/share.</li>
<li>The issue is a combination of fresh issue of 11.4M equity shares aggregating to INR900M and offer for sale of up to 9.5M equity shares aggregating to INR750M.</li>
<li>The company will use IPO proceeds for funding capex for opening 19 new IVF centers across India and repayment of outstanding loan/borrowings.</li>
</ul>


Gaudium IVF IPO will open for subscription on February 20 and close on February 24, with listing on February 27. The IPO price band has been set at INR 75–79/share.
The issue is a combination of fresh issue of 11.4M equity shares aggregating to INR900M and offer for sale of up to 9.5M equity shares aggregating to INR750M.
The company will use IPO proceeds for funding capex for opening 19 new IVF centers across India and repayment of outstanding loan/borrowings.


Gaudium IVF and Women Health IPO Review: Gaudy, But Not Fertile Enough